Achromatopsia 3: Clinical Trials

2 trials for Achromatopsia 3, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. .

Follow Achromatopsia 3: new trials by email Literature Review of Achromatopsia 3 trials Research Report on Achromatopsia 3

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Inherited Retinal Degenerative Disease Registry
Eye Diseases Hereditary, Retinal Disease
RecruitingFoundation Fighting Blindness200002014-06-012026-05-19
Clinical and Genetic Characterization of Individuals With Achromatopsia
Achromatopsia
CompletedBeacon Therapeutics562013-06-012017-10-13

Narrower conditions

Color Vision Defects (2)  ·  Abetalipoproteinemia (1)  ·  Bardet-Biedl Syndrome (1)  ·  Charcot-Marie-Tooth Disease (1)  ·  Choroideremia (1)  ·  Cone Dystrophy (1)  ·  Cone-Rod Dystrophies (1)  ·  Enhanced S-Cone Syndrome (1)  ·  Eye Diseases, Hereditary (1)  ·  Fundus Albipunctatus (1)  ·  Gyrate Atrophy (1)  ·  Kearns-Sayre Syndrome (1)  ·  Leber Congenital Amaurosis (1)  ·  Neuronal Ceroid-Lipofuscinoses (1)

Broader conditions

Eye Diseases (2)  ·  Nervous System Diseases (2)  ·  Neurologic Manifestations (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Sensation Disorders (2)  ·  Signs and Symptoms (2)  ·  Vision Disorders (2)  ·  Abnormalities, Multiple (1)  ·  Blindness (1)  ·  Brain Diseases (1)  ·  Brain Diseases, Metabolic (1)  ·  Brain Diseases, Metabolic, Inborn (1)  ·  Cardiomyopathies (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Diseases (1)

Sponsors

Beacon Therapeutics (1)  ·  Foundation Fighting Blindness (1)

Countries

United States (2)

Top investigators

Matt Feinsod, MD (1)  ·  Todd Durham, PhD (1)

Results publications

PMID 27479814

NIH funding

R24EY022023 (1)